Agilent Technologies, Inc. $A Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 9.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,087,878 shares of the medical research company’s stock after selling 208,538 shares during the period. Bank of New York Mellon Corp owned 0.73% of Agilent Technologies worth $246,390,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Verdence Capital Advisors LLC raised its stake in Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock worth $215,000 after acquiring an additional 86 shares during the last quarter. Burney Co. increased its holdings in shares of Agilent Technologies by 4.8% in the second quarter. Burney Co. now owns 1,957 shares of the medical research company’s stock valued at $231,000 after purchasing an additional 90 shares during the period. Valeo Financial Advisors LLC raised its stake in shares of Agilent Technologies by 3.0% in the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock worth $403,000 after purchasing an additional 102 shares during the last quarter. Cary Street Partners Financial LLC lifted its holdings in shares of Agilent Technologies by 2.9% during the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock worth $431,000 after purchasing an additional 103 shares during the period. Finally, Stratos Wealth Partners LTD. boosted its position in Agilent Technologies by 0.3% in the first quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after buying an additional 124 shares during the last quarter. 87.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on A. TD Cowen raised their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Rothschild & Co Redburn initiated coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Finally, UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $130.00 to $170.00 in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Trading Up 1.2%

Shares of Agilent Technologies stock opened at $146.46 on Wednesday. The firm has a 50-day simple moving average of $134.05 and a two-hundred day simple moving average of $121.62. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a market cap of $41.52 billion, a P/E ratio of 34.38, a price-to-earnings-growth ratio of 4.67 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is presently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.